[1] |
Langan SM, Irvine AD, Weidinger S. Atopic dermatitis[J]. Lancet, 2020,396(10247):345⁃360. doi: 10.1016/S0140⁃6736(20)31286⁃1.
|
[2] |
Weidinger S, Beck LA, Bieber T, et al. Atopic dermatitis[J]. Nat Rev Dis Primers, 2018,4(1):1. doi: 10.1038/s41572⁃018⁃0001⁃z.
|
[3] |
Leung DY. Atopic dermatitis: new insights and opportunities for therapeutic intervention[J]. J Allergy Clin Immunol, 2000,105(5):860⁃876. doi: 10.1067/mai.2000.106484.
|
[4] |
Bieber T, Simpson EL, Silverberg JI, et al. Abrocitinib versus placebo or dupilumab for atopic dermatitis[J]. N Engl J Med, 2021,384(12):1101⁃1112. doi: 10.1056/NEJMoa2019380.
|
[5] |
Frazier W, Bhardwaj N. Atopic dermatitis: diagnosis and treatment[J]. Am Fam Physician, 2020,101(10):590⁃598.
|
[6] |
Svoboda SA, Johnson N, Phillips M. Dermatologic applications and safety considerations of Janus kinase inhibitors[J]. Skin Therapy Lett, 2020,25(4):6⁃11.
|
[7] |
Szalus K, Trzeciak M, Nowicki RJ. JAK⁃STAT inhibitors in atopic dermatitis from pathogenesis to clinical trials results[J]. Microorganisms, 2020,8(11):1743. doi: 10.3390/microorganisms 8111743.
|
[8] |
Zeng J, Du H, Zhang Y, et al. Efficacy of topical acidified aliphatic ester for treatment of axillary osmidrosis by rebalancing skin microecology[J]. Dermatol Ther, 2021,34(2):e14844. doi: 10.1111/dth.14844.
|
[9] |
Zeng J, Lei L, Zeng Q, et al. Ozone therapy attenuates NF⁃κB⁃mediated local inflammatory response and activation of Th17 cells in treatment for psoriasis[J]. Int J Biol Sci, 2020,16(11):1833⁃1845. doi: 10.7150/ijbs.41940.
|
[10] |
张宇, 韩悦, 徐蓓蕾, 等. 卵清蛋白联合卡泊三醇诱导构建特应性皮炎小鼠模型[J]. 中华皮肤科杂志, 2019,52(7):481⁃485. doi: 10.3760/cma.j.issn.0412⁃4030.2019.07.007.
|
[11] |
Moosbrugger⁃Martinz V, Schmuth M, Dubrac S. A mouse model for atopic dermatitis using topical application of vitamin D3 or of its analog MC903[J]. Methods Mol Biol, 2017,1559:91⁃106. doi: 10.1007/978⁃1⁃4939⁃6786⁃5_8.
|
[12] |
Sakai K, Sanders KM, Youssef MR, et al. Mouse model of imiquimod⁃induced psoriatic itch[J]. Pain, 2016,157(11):2536⁃2543. doi: 10.1097/j.pain.0000000000000674.
|
[13] |
陈桂芳, 高娟, 杨卫平, 等. 乌梅丸对特应性皮炎小鼠的药效作用[J]. 中成药, 2022,44(12):4004⁃4008. doi: 10.3969/j.issn. 1001⁃1528.2022.12.044.
|
[14] |
李文昭, 蒋晴, 唐礼荣. 含山茶油保湿乳抗湿疹、抗炎症的体外研究[J]. 香料香精化妆品, 2022,26(5):113⁃117,129. doi: 10.3969/j.issn.1000⁃4475.2022.05.021.
|
[15] |
Fu Z, Xie Y, Zeng L, et al. Ozonated oil alleviates dinitrochlorobenzene⁃induced allergic contact dermatitis via inhibiting the FcεRⅠ/Syk signaling pathway[J]. Zhong Nan Da Xue Xue Bao Yi Xue Ban, 2023,48(1):1⁃14. doi: 10.11817/j.issn.1672⁃7347.2023.220082.
|
[16] |
Tokura Y, Hayano S. Subtypes of atopic dermatitis: from phenotype to endotype[J]. Allergol Int, 2022,71(1):14⁃24. doi: 10.1016/j.alit.2021.07.003.
|
[17] |
Kasai H, Kawasaki H, Fukushima⁃Nomura A, et al. Stratification of atopic dermatitis patients by patterns of response to proactive therapy with topical tacrolimus: low serum IgE levels and inadequately controlled disease activity at the start of treatment predict its failure[J]. Ann Med, 2021,53(1):2205⁃2214. doi: 10.1080/07853890.2021.2004319.
|
[18] |
Lee SJ, Kim SE, Shin KO, et al. Dupilumab therapy improves stratum corneum hydration and skin dysbiosis in patients with atopic dermatitis[J]. Allergy Asthma Immunol Res, 2021,13(5):762⁃775. doi: 10.4168/aair.2021.13.5.762.
|
[19] |
Wang L, Xian YF, Loo S, et al. Baicalin ameliorates 2,4⁃dinitrochlorobenzene⁃induced atopic dermatitis⁃like skin lesions in mice through modulating skin barrier function, gut microbiota and JAK/STAT pathway[J]. Bioorg Chem, 2022,119:105538. doi: 10.1016/j.bioorg.2021.105538.
|
[20] |
Zeng J, Du H, Zhang Y, et al. Efficacy of topical acidified aliphatic ester for treatment of axillary osmidrosis by rebalancing skin microecology[J]. Dermatol Ther, 2021,34(2):e14844. doi: 10.1111/dth.14844.
|
[21] |
Fyhrquist N, Muirhead G, Prast⁃Nielsen S, et al. Microbe⁃host interplay in atopic dermatitis and psoriasis[J]. Nat Commun, 2019,10(1):4703. doi: 10.1038/s41467⁃019⁃12253⁃y.
|